TY - JOUR
T1 - Restoration of T cell responsiveness by thymosin
T2 - development of antituberculous resistance in BCG infected animals
AU - Morrison, N. E.
AU - Collins, F. M.
PY - 1976
Y1 - 1976
N2 - T cell depleted (adult thymectomized, lethally irradiated, bone marrow reconstituted [THXB]), sham thymectomized (XB) and normal control mice were injected daily with 3 mg of calf thymosin for 16 days. On day 8 of the treatment, the mice, together with untreated controls, were infected intravenously with 4 X 106 viable Mycobacterium bovis (BCG Montreal). Growth of the BCG in the lungs and spleens was compared quantitatively for up to 100 days. Thymosin treatment reversed the progressive weight loss seen in BCG infected THXB mice and prevented their death due to the ongoing mycobacteriosis that developed in the T cell depleted animal. There was a late developing anti mycobacterial response in the thymosin treated THXB mice, which resulted in a progressive decline in viability for the lung and spleen populations over the 40 to 80 day period, when the corresponding counts for the untreated THXB mice remained relatively constant. The histopathology of the lung and the increased antibacterial activity seen in the thymosin treated THXB mice correlated with decreased [3H]deoxyribonucleic acid levels seen in the lungs and spleen compared with that present in the T cell depleted controls.
AB - T cell depleted (adult thymectomized, lethally irradiated, bone marrow reconstituted [THXB]), sham thymectomized (XB) and normal control mice were injected daily with 3 mg of calf thymosin for 16 days. On day 8 of the treatment, the mice, together with untreated controls, were infected intravenously with 4 X 106 viable Mycobacterium bovis (BCG Montreal). Growth of the BCG in the lungs and spleens was compared quantitatively for up to 100 days. Thymosin treatment reversed the progressive weight loss seen in BCG infected THXB mice and prevented their death due to the ongoing mycobacteriosis that developed in the T cell depleted animal. There was a late developing anti mycobacterial response in the thymosin treated THXB mice, which resulted in a progressive decline in viability for the lung and spleen populations over the 40 to 80 day period, when the corresponding counts for the untreated THXB mice remained relatively constant. The histopathology of the lung and the increased antibacterial activity seen in the thymosin treated THXB mice correlated with decreased [3H]deoxyribonucleic acid levels seen in the lungs and spleen compared with that present in the T cell depleted controls.
UR - http://www.scopus.com/inward/record.url?scp=0017265087&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017265087&partnerID=8YFLogxK
U2 - 10.1128/iai.13.2.554-563.1976
DO - 10.1128/iai.13.2.554-563.1976
M3 - Article
C2 - 770334
AN - SCOPUS:0017265087
SN - 0019-9567
VL - 13
SP - 554
EP - 563
JO - Infection and Immunity
JF - Infection and Immunity
IS - 2
ER -